By Canadian Press

J&J vaccine can be used for people over 30 but mRNA vaccines still preferred: NACI

May 3, 2021 | 12:34 PM

OTTAWA — The National Advisory Committee on Immunization says the Johnson & Johnson vaccine should be limited to people over the age of 30 who don’t want to wait for Pfizer-BioNTech or Moderna. 

The advice is almost identical to that issued for the Oxford-AstraZeneca vaccine last month and comes as both are suspected of causing a new and very rare blood clotting syndrome.

In Canada there have been seven known cases of vaccine-induced thrombotic thrombocytopenia, or VITT, one of them fatal. 

As of April 24, 1.7 million people in Canada have been given at least one dose of the AstraZeneca vaccine.

No J&J doses have been injected in Canada thus far, but in the U.S. they have documented 17 cases of the blood-clotting disorder in about eight million doses given.

Court proceedings

'The impact of this trauma will echo for generations': court case surrounding La Ronge woman's death reaches conclusion

23h ago

Going Global

P.A.'s Zablocki named to Team Canada for U18 Women's World Championships

23h ago

Election 2024

Birch Hills staff won't share election decision

23h ago

Canada’s first 300,000 doses of J&J are on hold at a Toronto-area warehouse pending investigation to ensure they are safe after discovering they were partly made at an American facility cited for safety and quality-control violations.

This report by The Canadian Press was first published May 3, 2021.

Mia Rabson, The Canadian Press